Professor Sir Kenneth Calman noted that the issues surrounding inability to access interferon treatment for Hepatitis C "were common across the NHS when new drugs or treatments emerged."
Chronology Information
Date:
Chapter/issue
Access to Treatment
Key Person(s)
Sir Kenneth Charles Calman KCB DL